



Piramal Pharma moves SC against Gujarat pollution body's plant closure order
Subscribe to enjoy similar stories. Piramal Pharma Ltd has moved the Supreme Court against a Gujarat Pollution Control Board order directing the immediate closure of its Dahej manufacturing unit over alleged environmental violations. The company is also contesting a direction allowing the encashment of a ₹15 lakh bank guarantee.
The plea is slated to be heard on 9 February before a bench led by Chief Justice of India Surya Kant, along with Justices Joymalya Bagchi and N.V. Anjaria. On 5 February, the Gujarat high court refused to grant relief to the Mumbai-based pharmaceutical company.
Piramal Pharma’s Dahej facility, located in the Gujarat Industrial Development Corporation industrial area, is one of the company’s 10 manufacturing sites in India and produces key starting materials (KSMs) for complex hospital generics such as the inhaled anaesthetic sevoflurane, forming part of a vertically integrated inhalation anaesthesia chain that is completed at its Digwal plant. The Dahej facility is a World Health Organization-Good Manufacturing Practices (WHO-GMP) compliant manufacturing plant. The company, in an exchange filing on 4 February, said the financial and operational impact of the plant closure was “not ascertainable at this point in time".
Piramal’s complex hospital generics business clocked a revenue of ₹1,948 crore in the first nine months of 2025-26, marginally up by 1% year-on-year. The Gujarat Pollution Control Board's action followed an incident involving the alleged illegal dumping of hazardous waste. The regulator said that on 30 January 2026, a tanker carrying spent hydrochloric acid left Piramal Pharma’s Dahej facility for delivery to an authorized waste treatment unit in Surendranagar district.
Read on livemint.com